Marie‐Françoise Avril

Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome

Véronique Winnepenninckx, Vladimir Lazar, Stefan Michiels et al. · JNCI Journal of the National Cancer Institute · 2006 · 478 citations

Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study

Marie‐Françoise Avril, Steinar Aamdal, Jean‐Jacques Grob et al. · Journal of Clinical Oncology · 2004 · 470 citations

Genome-wide association study identifies three loci associated with melanoma risk

D. Timothy Bishop, Florence Démenais, Mark M. Iles et al. · Nature Genetics · 2009 · 457 citations · Full text

Genome-wide Association Study, Cancer Risk, Genetics +9

Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

E. Maubec, Peter Petrow, Isabelle Scheer-Senyarich et al. · Journal of Clinical Oncology · 2011 · 456 citations · Full text

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 364 citations · Full text

Surgical Oncology, Medicine, Melanoma +8